Epsilogen, a leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, has published phase 1 data from the first ever clinical trial of an IgE antibody therapeutic in Nature Communications.
Inspired Thinking Group (ITG) the technology-led multichannel marketing activation business, has launched ITG Health to deliver an ‘automation-first approach’ to the life sciences industry.
Vial, a CRO providing clinical trial management services, has partnered with biopharma company Nielsen BioSciences to study the safety and efficacy of CANDIN, a treatment for common warts.
Acesion Pharma has announced positive data from pre-clinical studies with AP31969, developed for chronic oral maintenance treatment to prevent atrial fibrillation (AF) recurrence.
The clinical stage company announces that its potential treatment for relapsed or refractory multiple myeloma receives nod for speedier review by the FDA.
Israel’s Sheba Medical Center, the largest hospital in the Middle East region, has initiated a collaborative project with Regeneron focused on oncology research and accelerating the development of potential novel therapeutics.
The DATAcc has released a collection of open-access resources that are intended to help users build inclusivity into digital health measurement products.
Zenith-Cognizant Technologies emerges from an acquisition aimed to streamline solutions as more complex “smart factories” become a greater focus in the biopharmaceutical industry.
Translational research faces new challenges – and opportunities – with the rapid growth in precision medicine and new drug modalities, as the industry looks to quickly bring new treatments to patients.
